'Real growth and opportunity are going to come from GLP-1'
Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

'The formulations business been a growth driver'
Rediff.com24 Feb 2024

'However, we have seen weakness in our active pharmaceutical ingredients business.'